GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lipigon Pharmaceuticals AB (OSTO:LPGO) » Definitions » Book Value per Share

Lipigon Pharmaceuticals AB (OSTO:LPGO) Book Value per Share : kr0.23 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Lipigon Pharmaceuticals AB Book Value per Share?

Lipigon Pharmaceuticals AB's book value per share for the quarter that ended in Dec. 2023 was kr0.23.

During the past 12 months, Lipigon Pharmaceuticals AB's average Book Value Per Share Growth Rate was 42.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -39.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Lipigon Pharmaceuticals AB was -3.00% per year. The lowest was -39.90% per year. And the median was -21.45% per year.

Lipigon Pharmaceuticals AB's current price is kr0.294. Its book value per share for the quarter that ended in Dec. 2023 was kr0.23. Hence, today's PB Ratio of Lipigon Pharmaceuticals AB is 1.31.

During the past 6 years, the highest P/B Ratio of Lipigon Pharmaceuticals AB was 7.02. The lowest was 0.65. And the median was 1.62.


Lipigon Pharmaceuticals AB Book Value per Share Historical Data

The historical data trend for Lipigon Pharmaceuticals AB's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lipigon Pharmaceuticals AB Book Value per Share Chart

Lipigon Pharmaceuticals AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Book Value per Share
Get a 7-Day Free Trial 0.17 1.04 1.73 0.16 0.23

Lipigon Pharmaceuticals AB Quarterly Data
Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.53 0.16 0.35 0.28 0.23

Competitive Comparison of Lipigon Pharmaceuticals AB's Book Value per Share

For the Biotechnology subindustry, Lipigon Pharmaceuticals AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lipigon Pharmaceuticals AB's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lipigon Pharmaceuticals AB's PB Ratio distribution charts can be found below:

* The bar in red indicates where Lipigon Pharmaceuticals AB's PB Ratio falls into.



Lipigon Pharmaceuticals AB Book Value per Share Calculation

Lipigon Pharmaceuticals AB's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(28.44-0.00)/126.42
=0.22

Lipigon Pharmaceuticals AB's Book Value Per Share for the quarter that ended in Dec. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(28.44-0.00)/126.42
=0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Lipigon Pharmaceuticals AB  (OSTO:LPGO) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Lipigon Pharmaceuticals AB Book Value per Share Related Terms

Thank you for viewing the detailed overview of Lipigon Pharmaceuticals AB's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Lipigon Pharmaceuticals AB (OSTO:LPGO) Business Description

Traded in Other Exchanges
Address
Tvistevagen 48 C, Umea, SWE, 90736
Lipigon Pharmaceuticals AB develops medicines for diseases caused by disorders of the body's handling of fats. It focuses on orphan drugs for unusual diseases where there is no adequate treatment.

Lipigon Pharmaceuticals AB (OSTO:LPGO) Headlines

No Headlines